Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model

Kun-Hung Lee, Wan-Ching Yen, Wen‐Hsing Lin, Peichen Wang, You-Liang Lai, Yu‐Chieh Su, Chunyu Chang, Cai-Syuan Wu, Yuchen Huang, Chen-Ming Yang,

Journal of Medicinal Chemistry · 2021 · 36 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

mesylate delayed the MC38 murine colon tumor growth and reversed the immunosuppressive tumor microenvironment with the increased M1/M2 ratio.

References

35